HK1050203A1 - Novel fusidic acid derivatives. - Google Patents

Novel fusidic acid derivatives.

Info

Publication number
HK1050203A1
HK1050203A1 HK03102419A HK03102419A HK1050203A1 HK 1050203 A1 HK1050203 A1 HK 1050203A1 HK 03102419 A HK03102419 A HK 03102419A HK 03102419 A HK03102419 A HK 03102419A HK 1050203 A1 HK1050203 A1 HK 1050203A1
Authority
HK
Hong Kong
Prior art keywords
acid derivatives
fusidic acid
novel
novel fusidic
treatment
Prior art date
Application number
HK03102419A
Other languages
English (en)
Inventor
Tore Duvold
Welf Von Daehne
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of HK1050203A1 publication Critical patent/HK1050203A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03102419A 1999-10-15 2003-04-04 Novel fusidic acid derivatives. HK1050203A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15955799P 1999-10-15 1999-10-15
PCT/DK2000/000578 WO2001029061A1 (en) 1999-10-15 2000-10-12 Novel fusidic acid derivatives

Publications (1)

Publication Number Publication Date
HK1050203A1 true HK1050203A1 (en) 2003-06-13

Family

ID=22573055

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102419A HK1050203A1 (en) 1999-10-15 2003-04-04 Novel fusidic acid derivatives.

Country Status (21)

Country Link
US (1) US6593319B1 (pt)
EP (1) EP1232173B1 (pt)
JP (1) JP2003512386A (pt)
KR (1) KR100795321B1 (pt)
CN (1) CN1157404C (pt)
AT (1) ATE241640T1 (pt)
AU (1) AU777352B2 (pt)
BR (1) BR0014751A (pt)
CA (1) CA2387600C (pt)
CZ (1) CZ20021265A3 (pt)
DE (1) DE60003074T2 (pt)
DK (1) DK1232173T3 (pt)
ES (1) ES2199867T3 (pt)
HK (1) HK1050203A1 (pt)
HU (1) HUP0203454A3 (pt)
MX (1) MXPA02003731A (pt)
NZ (1) NZ518034A (pt)
PL (1) PL203312B1 (pt)
PT (1) PT1232173E (pt)
RU (1) RU2257391C2 (pt)
WO (1) WO2001029061A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
US20060230643A1 (en) * 2005-03-23 2006-10-19 Michael Affleck Footwear with additional comfort
AU2006310873B2 (en) * 2005-10-31 2012-05-24 Leo Pharma A/S Preparation of an antibiotic crystalline fusidic acid
US9446226B2 (en) 2005-12-07 2016-09-20 Ramot At Tel-Aviv University Ltd. Drug-delivering composite structures
UA116622C2 (uk) * 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135267A (pt) 1971-02-25
US4162259A (en) 1975-12-03 1979-07-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab) Fusidic acid derivatives
US4259333A (en) 1977-10-28 1981-03-31 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Cephalosporines
GB2013084B (en) 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
EP0020794B1 (en) 1979-06-08 1983-01-12 Toko Yakuhin Kogyo Kabushiki Kaisha Creamy preparation containing steroid and process for the preparation thereof
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE892257A1 (en) 1989-07-13 1991-02-13 Elan Corp Anti-infective agent, process for its preparation and its¹use in therapy
US6103884A (en) 1996-03-27 2000-08-15 The University Of Michigan Glycosylated analogs of fusidic acid

Also Published As

Publication number Publication date
DK1232173T3 (da) 2003-09-29
PL355113A1 (en) 2004-04-05
JP2003512386A (ja) 2003-04-02
HUP0203454A3 (en) 2004-07-28
US6593319B1 (en) 2003-07-15
CA2387600A1 (en) 2001-04-26
KR100795321B1 (ko) 2008-01-21
CA2387600C (en) 2007-08-21
RU2257391C2 (ru) 2005-07-27
DE60003074T2 (de) 2004-03-18
EP1232173B1 (en) 2003-05-28
CZ20021265A3 (cs) 2003-02-12
WO2001029061A1 (en) 2001-04-26
HUP0203454A2 (hu) 2003-02-28
PT1232173E (pt) 2003-10-31
BR0014751A (pt) 2002-07-02
PL203312B1 (pl) 2009-09-30
ES2199867T3 (es) 2004-03-01
CN1157404C (zh) 2004-07-14
NZ518034A (en) 2003-10-31
MXPA02003731A (es) 2003-12-11
EP1232173A1 (en) 2002-08-21
AU777352B2 (en) 2004-10-14
KR20030022760A (ko) 2003-03-17
ATE241640T1 (de) 2003-06-15
AU7772800A (en) 2001-04-30
CN1378554A (zh) 2002-11-06
DE60003074D1 (de) 2003-07-03

Similar Documents

Publication Publication Date Title
PL361341A1 (en) Novel pharmaceutical composition
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
BG101118A (en) Therapeutical compounds
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
PL346143A1 (en) Tan-1057 derivatives
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
WO2001057042A3 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
HK1050203A1 (en) Novel fusidic acid derivatives.
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
AU2566101A (en) Compounds and methods for the treatment of pain
WO2002070537A3 (en) Fusidic acid derivatives
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
WO2000069841A3 (en) Benzofuranylaminoalcohols
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
EP1232748A4 (en) SUBSTITUTED NITROBENZENE-LIKE DERIVATIVE PRODUCT AS A MEDICINAL PRODUCT OR OTHER EFFICIENT PRODUCTS
GB0128071D0 (en) Medicament
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101012